Back to Search
Start Over
European Medicines Agency Viewpoint.
- Source :
- Pharmaceutical Technology Europe; Feb2024, Vol. 36 Issue 2, p11-14, 4p
- Publication Year :
- 2024
-
Abstract
- The article focuses on insights provided by Steffen Thirstrup, the chief medical officer at the European Medicines Agency, regarding regulatory challenges and successes in Europe's pharmaceutical landscape. Topics discussed include the impact of the COVID-19 pandemic on regulatory agility, challenges and collaborations in drug pricing and reimbursement, and efforts to enhance supply chain resilience and proximity to manufacturing infrastructure.
- Subjects :
- DRUG approval
INSTITUTIONAL cooperation
INVESTMENTS
VACCINES
INVENTORY shortages
HEALTH services administration
SOCIAL support
GOVERNMENT regulation
NEGOTIATION
CELLULAR therapy
MANUFACTURING industries
MEDICAL supplies
DRUG packaging
ORGANIZATIONAL goals
BUSINESS networks
HEALTH insurance reimbursement
SUPPLY chains
PATENTS
INTELLECTUAL property
DRUGS
INTERPROFESSIONAL relations
QUALITY assurance
GENE therapy
DRUG labeling
COMMUNICATION
PHARMACEUTICAL industry
COVID-19 pandemic
PUBLIC opinion
PSYCHOLOGICAL resilience
MEDICAL research
Subjects
Details
- Language :
- English
- ISSN :
- 17537967
- Volume :
- 36
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Pharmaceutical Technology Europe
- Publication Type :
- Periodical
- Accession number :
- 175597878